EP1013 is primarily used in the field of organic synthesis and pharmaceutical research. It serves as a key intermediate in the production of various active pharmaceutical ingredients (APIs), particularly those targeting neurological and metabolic disorders. Its unique structure allows for the development of compounds with enhanced bioavailability and therapeutic efficacy. Additionally, EP1013 is utilized in the development of novel drug delivery systems, improving the stability and controlled release of medications. Researchers also explore its potential in creating new materials with specific chemical properties for industrial applications.